Sarepta Therapeutics, Inc.(SRPT)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
SRPT | 2.02 B | - | -34.30% | -6.93% | -$1.57 | -9.48% | 0.70x | 0.00% | $24.68 | $14.68 |
VRTX | 130.44 B | 29.80x | 12.50% | 35.00% | $17.27 | 23.54% | 0.10x | 0.00% | $560.25 | $403.16 |
ALNY | 30.87 B | 38.91x | 66.90% | 16.13% | $5.93 | 96.56% | 2.21x | 0.00% | $495.55 | $197.81 |
INSM | 20.89 B | - | 296.10% | -76.94% | -$4.10 | -87.22% | 0.98x | 0.00% | $212.75 | $90.39 |
CRSP | 4.82 B | - | 1041.40% | 0.00% | -$4.74 | -26.10% | 0.45x | 0.00% | $75.06 | $44.12 |
NTLA | 1.66 B | - | -46.20% | 0.00% | -$3.35 | -55.44% | 0.10x | 0.00% | $28.25 | $7.95 |
Peer Valuation & Performance Analysis
Peer group analysis for Sarepta Therapeutics, Inc. (SRPT) compared to its primary competitors (including VRTX, ALNY, INSM) reveals distinct metrics. SRPT trades at a valuation discount relative to its competitors, with a P/E ratio of -12.2x versus the peer average of 6.3x (representing a 295% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, SRPT's revenue growth of -34.3% lags behind the peer average of 274.1%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of -6.9% is comparable to the peer average of -5.2%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• SRPT ranks #0 in P/E ratio, #5 in revenue growth, and #4 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $17.74 | $19.70 | $17.66 | $19.17 | 3,323,464 | +8.12% |
| 2026-10-19 | $17.25 | $17.83 | $17.12 | $17.73 | 2,328,400 | +3.68% |
| 2026-10-16 | $17.82 | $17.84 | $16.85 | $17.10 | 9,856,000 | -3.88% |
| 2026-10-15 | $16.96 | $17.96 | $16.61 | $17.79 | 4,041,900 | +5.70% |
| 2026-10-14 | $16.53 | $16.91 | $16.37 | $16.83 | 2,740,100 | +1.94% |
| 2026-10-13 | $17.12 | $17.23 | $16.41 | $16.51 | 3,684,000 | -5.33% |
| 2026-10-12 | $17.88 | $18.14 | $17.30 | $17.44 | 3,281,500 | -2.30% |
| 2026-10-09 | $18.25 | $18.53 | $17.68 | $17.85 | 3,014,800 | -1.98% |
| 2026-10-08 | $17.28 | $18.28 | $17.20 | $18.21 | 3,515,100 | +4.06% |
| 2026-10-07 | $17.28 | $17.67 | $16.98 | $17.50 | 2,872,800 | +1.10% |
| 2026-10-06 | $17.60 | $17.65 | $17.04 | $17.31 | 2,690,400 | -1.03% |
| 2026-10-05 | $17.39 | $17.55 | $17.10 | $17.49 | 2,198,100 | -0.06% |
| 2026-10-02 | $17.75 | $17.76 | $17.21 | $17.50 | 2,549,700 | -0.40% |
| 2026-10-01 | $18.14 | $18.25 | $17.52 | $17.57 | 2,884,300 | -3.57% |
| 2026-09-30 | $18.64 | $18.69 | $18.06 | $18.22 | 1,995,000 | -2.25% |
Explore More Analysis for SRPT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.